Streetbeat News

Analyst Ratings

COF

Four analysts have recently assessed Capital One Financial (NYSE:COF), with opinions ranging from bullish to bearish. The average 12-month price target has increased by 5.06% to $166. Analysts have adjusted their ratings and price targets, reflecting their views on the company's market position and financial performance. Despite positive revenue growth, Capital One faces challenges with profitability and returns on equity and assets.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 5:00 pm

ALTM

Mizuho analyst John Roberts maintains a Neutral rating on Arcadium Lithium (NYSE:ALTM) but raises the price target from $3 to $4.3.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:59 pm

INTA

Intapp shares declined following a downgrade by Barclays from Overweight to Equal-Weight, with the price target remaining at $44.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:57 pm

ASO

Academy Sports and Outdoors shares fell after Evercore ISI Group downgraded the stock from Outperform to In-Line and reduced its price target from $65 to $60.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:52 pm

CVNA

Wedbush analyst Seth Basham maintains a Neutral rating on Carvana (NYSE:CVNA) but raises the price target from $150 to $175.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:48 pm

CLOV

Clover Health Investments shares are trading lower following UBS's initiation of coverage with a Neutral rating and a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:48 pm

HALO

Halozyme Therapeutics shares declined following a downgrade by Wells Fargo from Overweight to Equal-Weight.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:46 pm

APD

Vertical Research has upgraded Air Products & Chemicals (NYSE:APD) from Hold to Buy, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:46 pm

CVS

CVS Health has seen unusual options activity with over 14 trades totaling $1,086,658. The stock is currently priced at $64.72, with a slight increase of 0.2%. Analysts have mixed ratings, with price targets ranging from $62 to $85. The options activity suggests a focus on a price band between $30 and $67.5.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 4:45 pm

BLK

Morgan Stanley analyst Mike Cyprys maintains an Overweight rating on BlackRock and raises the price target from $1036 to $1150.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:45 pm